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Abstract
Background: The human intestinal microbiota is a crucial factor in the pathogenesis of various diseases, such as metabolic
syndrome or inflammatory bowel disease (IBD). Yet, knowledge about the role of environmental factors such as smoking
(which is known to influence theses aforementioned disease states) on the complex microbial composition is sparse. We
aimed to investigate the role of smoking cessation on intestinal microbial composition in 10 healthy smoking subjects
undergoing controlled smoking cessation.
Methods: During the observational period of 9 weeks repetitive stool samples were collected. Based on abundance of 16S
rRNA genes bacterial composition was analysed and compared to 10 control subjects (5 continuing smokers and 5 non-
smokers) by means of Terminal Restriction Fragment Length Polymorphism analysis and high-throughput sequencing.
Results: Profound shifts in the microbial composition after smoking cessation were observed with an increase of Firmicutes
and Actinobacteria and a lower proportion of Bacteroidetes and Proteobacteria on the phylum level. In addition, after
smoking cessation there was an increase in microbial diversity.
Conclusions: These results indicate that smoking is an environmental factor modulating the composition of human gut
microbiota. The observed changes after smoking cessation revealed to be similar to the previously reported differences in
obese compared to lean humans and mice respectively, suggesting a potential pathogenetic link between weight gain and
smoking cessation. In addition they give rise to a potential association of smoking status and the course of IBD.
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Introduction
The human intestinal microbiota has important influences on
the development of innate immunity [1,2], regulation of epithelial
development and nutrition [3,4]. The gut microbiota and
alterations in its complex composition have been identified as an
contributing factor in the pathogenesis of various diseases, such as
inflammatory bowel disease (IBD) [5,6] or irritable bowel
syndrome [7–9]. Cigarette smoking is considered to be one of
the most important environmental risk factors in IBD pathogenesis
[10–13]. In the two main subtypes of IBD, Crohn’s disease (CD)
and ulcerative colitis (UC), there is a known divergent effect of
smoking on the disease course. While smoking is clearly
detrimental in CD [14,15] (in many [16] but not all [14] studies
this seems especially to be the case with regard to ileal CD) it has
a well-known protective effect in UC with a lower incidence of the
disease in smokers [11] and a more severe disease course after
smoking cessation [17]. In addition, the gut microbiota seems to
play a crucial role in the pathogenesis of obesity and the metabolic
syndrome [18,19], characterized by distinctive shifts in the relative
abundance of mayor phyla in obese vs. lean humans [20,21] and
mice [22], respectively. Around 80% of individuals who cease
smoking gain weight to an average of 7–8 kg [23], interestingly
even despite stable [24] or even decreased [25] total caloric intake.
Furthermore an alteration of the oropharyngeal and tracheal
microbiota in smokers compared to non-smokers has been shown
recently [26].
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In the last few years considerable progress has been achieved in
the comprehension of the enormous diversity of the intestinal
microbiota, its component genes (microbiome) and host genetic
factors influencing its development after birth with the spread of
culture independent methods [27]. Nevertheless, the precise role
of environmental factors, such as nutrition, medication use or
smoking on the composition of the gut microbiota is largely
unknown. Accordingly, and in view of the above mentioned
microbial discoveries with regard to the pathogenesis of obesity
and IBD we aimed to investigate the development of human
intestinal microbial composition during controlled smoking
cessation. Microbiota analyses of repetitive stool samples were
performed in the course of a controlled prospective study with 10
healthy smoking subjects undergoing smoking cessation (interven-
tion group) and 10 healthy control subjects, 5 continuous smoking
(control group smokers) and 5 non-smoking (control group non-
smokers) subjects. Our hypothesis at the beginning of the study
was, that smoking may influence the composition of the intestinal
microbiota and accordingly, that smoking cessation may also alter
intestinal microbial composition. We further hypothesized, that
the weight change after smoking cessation migt be associated with
a shift to a microbiota pattern harbouring similarities to the
recently characterized found in the ‘‘obese microbiota’’ in humans
or animal models and that these microbial shifts might indicate
a pattern associated with a pro-inflammatory situation.
Materials and Methods
Study design
The study was fully approved by the local Ethics Committee.
Observation period was 9 weeks (1 week before and 8 weeks after
cessation of smoking) including 5 study visits, among them t1
(Screening), t2 and t3 (4 and 8 weeks respectively after smoking
cessation). All 5 study visits took place in facilities of the smoking
consulting program of the University Hospital Zurich, Switzer-
land. At screening visit (S = t1) written informed consent was
obtained. Inclusion (age $18 and #60 years; written consent;
smoker (defined as daily cigarette consumption of $10); readiness
to quit smoking) and exclusion criteria (intercurrent bacterial or
viral disease of the colon; pregnancy, lactation; patients with more
than 40 mg prednisone per day (or equivalent); diabetes mellitus;
severe comorbid disease (making a participation at the study not
possible according to opinion of the test physician); justified doubt
about the co-operation of the patient; patients with active infection
or systemic antibiotic, antiviral, or antifungal treatment in the last
3 weeks before the screening investigation; patients with alcohol or
drug misuse in the last year; patients with short bowel syndrome;
patients with parenteral nutrition; severe comorbid conditions)
were checked. Full medical record, medication use, alcohol intake
and smoking habits were assessed and a physical examination
including body height and weight was performed. During the
whole study period intensive counseling was provided by both,
physicians and psychologists with special experience in consulta-
tion in smoking cessation. Subjects were instructed to keep on
smoking according to their regular smoking habits up to baseline
(T0; 7–10 days after screening). Baseline was prespecified as the
date of complete smoking cessation.
At the baseline study visit and the subsequent control visits
1 week (T1), 4 weeks (T4) and 8 weeks (T8) after smoking
cessation physical examination including body weight and
assessment of medication intake was re-performed. Mandatory
strict adherence to complete smoking cessation was verified by
a breath carbon monoxide monitor (piCO+TM SmokerlyzerH;
Bedfont Scientific Ltd & decode.uk). Measuring was done in
concordance to the guidance of the manufacturer, always
performed under direct observation of a study physician. A cut-
off level of .6 ppm was chosen to define current smoking [28];
a single level above 6 ppm or self-declaration of on-going smoking
after T0 led to study drop out. Supplemental nicotine adminis-
tration or use of smoking cessation medications was not allowed.
Stool samples, which have been shown to be representative of
inter-individual differences in microbial composition [29], were
collected at every study visit. Samples of 3 time points were used
for further analyses; at screening (one week prior to smoking
cessation, t1), 4 and 8 weeks after smoking cessation (t2, t3)
corresponding to week 0, 5 and 9 in the continuing smoking and
non-smoking subjects. Study subjects had to complete a daily food-
frequency protocol three times over a period of 7 consecutive days
(one week before t1, t2, and t3), allowing assessment of food
patterns in a qualitative and approximated quantitative manner.
Microbiota analyses
Stool samples were collected in conventional fecal samples
storage tubes containing phosphate buffered saline (PBS)/Ethanol,
the latter leading to an immediate denaturation of bacterial cell
wall. Methods for T-RFLP are depicted in the SI Materials and
Methods. For pyrosequencing genomic DNA from fecal pellets
was extracted and quantified. We amplified variable region V1–
V2 of the 16S rRNA gene using forward and reverse primer, the
latter containing a unique 10 base multiplex identifier (MIDs
designated as XXXXXXXXXX) to tag each Polymerase Chain
Reaction (PCR) product. Replicate PCRs were performed for each
sample and negative controls. The amplified product was run on
agarose gel and the specific band was excised and amplicons were
purified. Equal amount of PCR products were mixed in a single
tube and sequenced using RocheH 454 titanium chemistry.
Replicate PCRs were performed for each sample as well as
negative controls (water). All sequence reads were screened and
filtered for quality and length; chimeric sequences were removed
as were sequences failing quality criteria (further details in the SI
Materials and Methods). Taxonomy was assigned by comparison
against the Ribosomal Database Project (RDP) release 10 [30].
The complete raw sequencing data of this study is accessible via
the European Nucleotide Archive in the Sequence Read Archive
(SRA) under the study accession number ERP002222 (available at
the URL http://www.ebi.ac.uk/ena/data/view/ERP002222;
Samples accessions: ERS212677).
Statistical Analysis
Paired Student’s t-test was used for a comparison of average
daily calorie intake (and respective fraction of calories attributable
to carbohydrates, proteins, fat, fibres and alcohol). Analyses of the
T-RFLP data was performed using T-Rex (T-RFLP analysis
Expedited) [31]. A doubly centred Principal Component Analyses
(PCA), also known as the Additive Main Effects and Multiplicative
Interaction Model (AMMI) with 9 environments (intervention
group, control group smokers, control group non-smokers; each at
t1, t2 and t3) was performed. For the sequences obtained by
pyrosequencing paired Student’s t-test was used for taxonomy
based comparison of between group changes. Beforehand
skewness of value distribution was ruled out with StatViewTM.
Cd-hit [32] was used to identify and cluster similar sequences for
phylogenetic analyses and to define OTUs with the commonly
applied sequence identity cut-off of 0.97. Sequence alignment was
performed using NAST from the Greengenes server [33] including
all sequences with a minimum length of 150 bases. A phylogenetic
tree was constructed using FastTree 2. To perform a phylogeny-
based analyses of beta diversity we used Fast UniFrac [34],
Changes in Gut Microbiota after Smoking Cessation
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a bioinformatic software tool that can be used to characterize
variations in bacterial community membership over time in
dependency of external influences, such as nutrition or space in
a large numbers of samples and sequences. Analyses in Fast
UniFrac can be performed either by considering only the absolute
abundance of sequences in every sample (unweighted) or by taking
the relative abundance of bacterial species into account (here, the
branches of certain bacterial lineages are weighted according to
their quantitative occurrence). A normalization step can be
performed (each sample treated equally instead of each unit of
branch as in the non-normalized mode; for normalization the
UniFrac value is divided by the distance scale factor, which is the
average distance from the root of each sequence). Initially,
sequences were processed by identifying and selecting the
occurring OTU and a phylogenetic tree was built. A sample
distance matrix was constructed, showing the overall phylogenetic
distance between each pair of sequences. This matrix provides the
basis to conduct PCA and hierarchical clustering using the
UPGMA (Unweighted Pair Group Method with Arithmetic
Mean) algorithm.
Bonferroni correction was applied in case of multiple testing. As
a resampling method bootstrapping was performed including 75%
of available sequences in each run in altogether 1000 permutations
using the software tool QIIME [35] (Quantitative Insights Into
Microbial Ecology).
The term phylogenetic diversity was coined by Faith [36] and
characterizes the amount of biodiversity in a given sample by
summarizing the total length of all branches leading to the
investigated set of taxa in a phylogenetic tree, i.e. a quantification
of the phylogenetic heritage of organisms in a given set of species.
Alpha diversity was calculated using the Phylogenetic Diversity
Analyser (PDA) [37]. Rarefaction curves were constructed using
QIIME.
Results
Calorie intake and body weight in the course of smoking
cessation
During the observational period there was a mean 2.2 kg
increase in body weight in the 10 subjects undergoing smoking
cessation (mean body weight at screening 71.8 kg, corresponding
to a mean BMI of 24.1 kg/m2; mean body weight at T8 74.0 kg,
corresponding to a mean BMI of 24.8 kg/m2; Table S1).
However, neither a significant alteration of total average daily
calorie intake, nor the fraction of nutritional components
(carbohydrates, proteins, fat, fiber and alcohol) was identified
based on the weekly food-frequency-protocols as indicated in
Figure S1 and Tables S2, S3 (as a sole exception a slight but
significant increase in calorie intake from alcohol between t2 and
t3 was observed).
Alteration in the microbial composition, indicated by T-
RFLP analysis
As a first step we conducted a universal terminal-restriction
fragment length polymorphisms (T-RFLP) analysis. Doubly
centered Principal Component Analyses (PCA) of the resulting
data with 9 environments (intervention group, control group
smokers, control group non-smokers; each at t1, t2 and t3)
indicated a clear shift in the intervention group between samples
from t1 and t2, as well as t2 and t3. The observed shift was most
pronounced along the first principal component axis, representing
the major part of the observed difference (58.5%; Figure S2). No
such shift was observed in the non-smoking control group, where
a close clustering was maintained over the different time points. In
the smoking control group a somewhat wider separation was
detected, however almost exclusively along the second principal
component axis. The latter represents substantial less difference in
species composition (37.7%) as compared to the first principal
component axis (Figure S2, Table S4).
Differences in the abundance of sequences before and
after smoking cessation
For a more comprehensive analysis of the microbial diversity
harbored by the stool samples we next performed a 454
pyrosequencing approach to analyze the variable regions V1–V2
of the 16S rRNA gene. After applying an initial cleaning step on
the generated raw sequence data as described in the methods
section we generated a total of 3359902 sequences. The vast
majority of sequences (97.3%) could be assigned to four phyla:
Firmicutes (51.9%), Proteobacteria (33%), Bacteroidetes (7.1%) and
Actinobacteria (5.4%) (Further identified bacteria included members
of the phyla Verrucomicrobia, Lentisphaerae, Tenericutes, Cyanobacteria,
Synergistetes, Fusobacteria, Deinococcus-Thermus, TM7, Acidobacteria and
OD1, whereas 0.9% of sequences could not be classified
(Figure S3)).
We found an increase of sequences from Firmicutes and
Actinobacteria and a simultaneous decrease of the Proteobacteria and
Bacteroidetes fractions after smoking cessation (Figure 1a). These
changes were exclusively observed in the intervention group and
a substantial part of the shift occurred between t1 and t2. The
increase of Firmicutes and Actinobacteria as well as the decrease of
Proteobacteria between t1 and t2 in the intervention group was
significant in the paired Student’s T-Test (0.027, 0.014 and 0.041
respectively), while the decrease in the fraction of Bacteroidetes did
not reach statistical significance (0.109). Although the detected
changes between t1 and t2 seemed to be further accentuated
8 weeks after smoking cessation in t3 (except for the Proteobacteria)
the composition of phyla between t2 and t3 remained strikingly
similar with the exception of Bacteroidetes, pointing to both
a relatively brisk (within 4 weeks) and durable (8-week interval)
effect of smoking cessation on microbial composition. In contrast,
the composition of phyla in both control groups remained
relatively stable. Here not one single change in the composition
of phyla reached statistical significance (Figure 1b). However, the
observed changes in the control groups were not exclusively
restricted to the phylum level. Significant changes were also
detected on the genus level (Figure S5). We did not observe any
per individual correlation between changes in body weight and
microbial composition.
Differences in microbiota composition indicated by
phylogenetic microbial analyses
PCA including 9 environments revealed a clear separation of
bacterial community composition in the intervention group, most
pronounced between t1 and t2, whereas the control groups
clustered closely together (Figure 2 and Figure S6 for unweighted
and weighted analyses, respectively). UniFrac distance serves as
a measure of difference in the phylogenetic lineages between
different environments. The highest UniFrac distance was de-
termined in subjects undergoing smoking cessation, comparing the
time points prior to and after the intervention (I1 to I2 versus N1
to N2 and S1 to S2: p= 0.045; I1 to I3 versus N1 to N3 and S1 to
S3: p= 0.026). In contrast no significant differences between the
samples from the intervention and control groups were observed
after the intervention (I2 to I3 versus N2 to N3 and S2 to S3:
p = 0.244, not significant). These findings illustrate that the
samples prior to and after smoking cessation were more different
Changes in Gut Microbiota after Smoking Cessation
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to each other (Figure 3a). In addition, clustering the samples based
on the distance matrix the separation of bacterial lineages at t1
and t2 in the intervention group occurred significantly closer to the
root (i.e. higher UniFrac distance units) of the constructed tree
compared to any other separation process observed within
intervention and control groups. Weighted UniFrac Significance
reflected a significant difference between t1 and t2 (non-
normalized UniFrac Significance 0.036, with Bonferroni correc-
tion applied). After normalizing, significance was additionally
observed for t1 to t3, exclusively in the intervention group (,0.001
for both, t1 to t2 and t1 to t3, Bonferroni correction applied).
Jackknife analysis used as a statistical technique of repetitive
resampling (bootstrapping) revealed perfect reproducibility under-
lining robustness of our results (Figure S7).
Microbial diversity analyses (a-diversity)
Both Phylogenetic Diversity and endemic Phylogenetic Di-
versity [38] (the sum of all branch lengths of species exclusively
found in the respective environment) as measures for a-diversity
were shown to be substantially higher 4 weeks after smoking
cessation compared to the samples obtained whilst smoking. After
8 weeks there was still a trend towards increased diversity levels
compared to baseline. In the control groups both diversity indices
were relatively stable during the whole observation period
(Figure S8). Rarefaction curves, a means of correction for number
of sequences obtained per sample, underlined the increased
microbial diversity after smoking cessation (Figure 3b, Figure S9).
Discussion
The results of our controlled trial suggest that smoking is to be
included in the growing list of known factors influencing the
composition of the intestinal microbiota. We found evidence with
two independent methodological approaches that smoking cessa-
tion induces a substantial modification of the intestinal microbial
composition with no indication of any concomitant alteration in
nutrition. A variety of different analyses of the high-throughput
sequencing data indicated differences before and after smoking
cessation, suggestive for profound and robust microbial shifts. On
the phylum level strikingly even alterations regarding the major
four phyla were identified in the individuals undergoing smoking
cessation (Figure 1, Figure S4). On the level of OTUs quantitative
changes (relative abundance of some bacterial lineages in the
complex microbial mixture) are indicated by alterations in the
weighted UniFrac mode, while the similar findings in the
unweighted analyses in addition point to qualitative changes (i.e.
occurrence of new OTUs after smoking cessation and disappear-
ance of former OTUs prior to the intervention).
Figure 1. Comparison of the major phyla of the gut microbiota
before and after smoking cessation. (A) Phyla Composition. The
results for the intervention group (I) and the control groups (non-
smoking =N; smoking = S) are given for samples taken one week prior
to smoking cessation (t1) as well as four weeks (t2) and eight weeks (t3)
thereafter. Whereas the intervention group revealed a significant
increase in fractions of Firmicutes and Actinobacteria and a decrease
in fractions of Proteobacteria and Bacteroidetes, the microbiota of the
control groups remained rather stable. The phyla Tenericutes, Verruco-
microbia, Synergistetes, Fusobacteria, Deinococcus-Thermus, TM7, Acid-
obacteria and OD1 are summarized under ‘‘other’’. (B) Heat Map. The
result of paired Student’s t-test is shown on the phylum level with
a color coded heat map. Significance levels are shown in different colors
(shades of red, significant shifts in bacteria composition; shades of
yellow, green and blue, non-significant shifts) and are indicated by the
exact significance values within the colored squares of the graph. The
major changes in the microbiota in the intervention group were
observed between the time points before (t1) and after (t2, t3) smoking
cessation. In contrast no significant changes were detected in the
control groups and – with the exception of Bacteroidetes – after
smoking cessation between t2 and t3 in the intervention group (an
extended version of the heat map including all identified genera is
shown in Figure S5, n/a = not applicable).
doi:10.1371/journal.pone.0059260.g001
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Furthermore, aside from pure microbial shifts an increase in
microbial plurality is suggested by the increase in a-diversity after
smoking cessation (Figure 3b, Figure S9). However, due to the
limited observation period after smoking cessation, it is not
possible to draw any conclusions on a potential sustained long-
term increase of a-diversity due to smoking cessation. A long-term
effect towards an increased microbial richness rather appears
doubtful, as the initial increase in diversity somewhat mitigated
after 8 weeks in all our analyses of a-diversity. Also, there were no
substantial differences in a-diversity between smokers and non-
smokers in the control groups. Interestingly, in contrast to our
findings, oropharyngeal microbial diversity was found to be
increased in smokers compared to non-smokers [26]. Thus, to
clarify this issue further studies on the long-term effect of smoking
on a-diversity of the intestinal microbiota are necessary.
We observed similar shifts in microbial composition on the
phylum level after smoking cessation as described in obese versus
lean humans [21,20] and mice [22] (a lower proportion of
Bacteroidetes and a higher proportion of Firmicutes and Actinobacteria),
while a concomitant average weight gain of 2.2 kg during the
whole observational period occurred. However, neither a change
in total daily calorie intake nor nutritional components was
suggested owing to analyses of the food-frequency questionnaires.
Thus, the common perception that a change in dietary habits is
the key factor for weight gain after smoking cessation is challenged.
Our findings may suggest a potential role of an altered
composition of the intestinal microbiome and hence metabolome
with subsequent modifications in gut microbiota’s metabolic
function in the pathogenesis of weight gain after smoking
cessation.
The above mentioned disordered oropharyngeal and tracheal
microbial communities in smokers [26] appears to be intuitively
plausible due to the direct contact of cigarette smoke with the
respiratory epithelial cells and mucus harboring the local
microbiota. Possible pathophysiologic links explaining the in-
fluence of smoking and smoking cessation on the intestinal
microbial composition are much less evident. However, our study
was not designed to investigate potential causative mechanisms. In
addition, due to the study design it was not possible to investigate
whether there are any loco-regional differences such as for
instance between the terminal ileum and recto-sigmoid. This
would be of interest with regard to the discrepancy of smoking
between UC and CD.
Another limitation of our study is that despite the controlled
study setup to largely rule out external influences such as for
instance medication intake (e.g. antibiotics or supportive drugs for
smoking cessation) or non-adherence to strict smoking cessation,
we cannot completely ascertain lack of confounding effects such as
exercise or subtle changes in dietary habits unrecognized by
analysis of food-frequency protocols. However, the following
considerations argue against a major contributing role of hidden
dietary alterations. First, the assumption that an alteration of diet
and increase of calorie intake would explain the observed weight
gain is not based on robust evidence, as indications that increased
calorie intake is the principal explanation for weight gain after
smoking cessation are at best conflicting. In contrast, there are
Figure 2. Phylogeny-based Principal Component Analysis. Bacterial communities of the three different treatment groups were clustered
using PCA and the unweighted UniFrac distance matrix as an input (weighted PCA is shown in Figure S6). With PCA, a multivariate statistical analyses,
axes that reflect the largest part of sample variation are identified (Percentage values at the axes reflect the level of variation explained by each
principal coordinate; the first axis indicates the largest fraction of difference). Separation of the different sample collectives in 3 dimensions is
visualized. A separation of the samples from the intervention group (I), that is most predominant 4 weeks after smoking cessation, was revealed. In
contrast, the samples from the non-smoking (N) and smoking (S) control groups clustered together closely, thus reflecting their overall similar
microbial composition.
doi:10.1371/journal.pone.0059260.g002
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important studies suggesting alternative mechanisms for weight
gain, such as a decreased metabolic resting rate [39] or changes in
metabolic properties in the adipose tissue, in specific an increase of
the lipoprotein lipase activity [40]. While a smaller study found no
increase in calorie intake after smoking cessation in subjects
gaining weight [24], an indicator for alternative mechanisms for
the well-known effect of weight gain [23] are the results of the
multiple risk factor intervention trial [25]; one of the largest studies
ever performed in this field. This trial included more than 11000
men with an observational period of 6 years, thoroughly in-
vestigating weight gain and calorie intake in nonsmokers, quitters,
recidivists, and continued smokers in a usual care group in
comparison to a special intervention group with specific counsel-
ing. Interestingly, despite a reduced calorie intake and a generally
healthier diet after counseling compared to baseline, and an even
bigger reduction in calories compared to continuing smokers, men
who ceased smoking gained weight. This was strikingly in
contradiction to nonsmokers, continuing smokers, and even
recidivists, who all lost weight. Second, although alterations in
intestinal microbiota composition due to diet are well known,
profound shifts seem to necessitate a longer time period as a recent
human study found significant changes on the phylum level to
occur predominantly after 12 weeks [21]. In contrast no stable
switches between enterotype groups occurred in the short-term,
despite a controlled and randomized short-term feeding experi-
ment using two extremely divergent diets (high-fat/low-fiber
versus low-fat/high-fiber) [41]. Third, a uniform shift in the phyla
composition such as the one observed in our patients undergoing
smoking cessation (Figure S4) indeed might be assumed to occur
in interventions with prespecified and standardized major changes
of diet. But this would less likely to be expected in individually
different and uncontrolled slight dietary changes undetected by
food-frequency protocols.
Although we identified continuous microbial shifts 8 weeks after
smoking cessation, this relatively short observational period does
not permit conclusions about a long-term alteration. Nevertheless,
the continuing increase in body mass observed in subsequent
4 years [23] after the first year after smoking cessation (where the
major part of the weight gain occurs) points to a potential
sustained microbial alteration. Larger prospective long-term
studies are needed to address this issue.
Although the role of cigarette smoking as one of the most
important environmental risk factor in the pathogenesis of IBD is
well established [10–13], the numerous epidemiological reports on
smoking status and course of IBD are in sharp contrast with the
very limited mechanistic explorations of the effect of smoking
cigarettes on the gut and intestinal inflammation. The molecular
and cellular mechanisms by which smoking interferes with the
pathogenesis of CD and UC are only poorly understood. While
several potential mechanisms, such as modulation of mucosal
immune responses, alterations in intestinal cytokine and eicosa-
noid levels or modifications in gut permeability have been
proposed, none of these hypotheses could hitherto offer a satisfying
explanation [42]. As the importance of the intestinal microbiota in
the pathogenesis of IBD is well established, the profound shifts in
the composition of the intestinal microbiota observed in our study
may shed some light to a potential pathogenetic link of cigarette
smoking, smoking cessation, and course of disease in IBD,
including the discrepancy in CD and UC. However, as we did
not investigate the intestinal microbial evolution during smoking
cessation specifically in patients with IBD, this potential pathoge-
netic link largely remains a speculative deduction and our findings
need to be confirmed in CD and UC patients. We nevertheless
believe, that the results of our observational study, demonstrating
intestinal microbial shifts after smoking cessation for the first time,
point to a potential interaction of disease-modifying factors in IBD.
This may give us a further piece of information with regard to an
enormously complex interplay, where we clearly are just at the
beginning of our understanding – the interplay of the intestinal
microbiota, chronic inflammatory bowel disease, systemic meta-
bolic interactions and environmental factors (such as smoking).
In conclusion, smoking cessation induces profound changes in
intestinal microbial composition. Interestingly, these changes
appear to occur in a comparable manner both microbiologically
and clinically (weight gain) as those induced by transplantation of
Figure 3. UniFrac distance between samples and rarefaction
curve of phylogenetic diversity. (A) Unweighted UniFrac distance.
The higher a UniFrac distance value between two samples the more
different the bacterial composition. The highest distance values were
determined for subjects undergoing smoking cessation between t1 and
t2 as well as between t1 and t3. All other distance values were
substantially smaller (error bars indicate SEM; *: p,0.05; ns: not
significant). (B) Rarefaction curves. These curves express the accumu-
lation of phylogenetic richness that would be obtained with continuous
sampling effort and hence minimize potential differences that would be
a result of the variable number of sequences obtained per sample. For
the control groups the three sampling time points were combined in
a single curve, while for the intervention group separated curves for t1,
t2 and t3 were depicted to visualize the increased phlyogenetic
diversity (PD) in the samples 4 weeks after smoking cessation (I2)
compared to I1 and I3 (additional indices of a-diversity are depicted in
Figure S9).
doi:10.1371/journal.pone.0059260.g003
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an ‘obese microbiota’ into lean mice [20]. These alterations in
conjunction with weight gain point to further evidence for the
assumed role of the intestinal microbiota and its metabolic
properties derived to the host in the pathogenesis of obesity and
the metabolic syndrome. Our findings invite confirmatory larger
and long-term studies as well as further research on the effect of
environmental factors on intestinal microbial composition.
Supporting Information
Figure S1 Average daily calorie intake. No significant
changes in total calorie intake or nutritional components were
observed before (t1) and after smoking cessation (t2, t3), except for
a modest increase in average daily alcohol consumption between
t2 and t3 (error bars indicating SEM; Carb: carbohydrate; da:
daily average). Further details on the individual calorie intake are
given Table S2 and S3.
(TIF)
Figure S2 PCA with 9 environments. Separation of the
samples from the intervention group (E7= I, t1; E8= I, t2; E9= I,
t3) alongside the first principal component axis (IPCA1) reflecting
the largest difference, 58.5% (as outlined in Table D, Table S4.).
There is a close association of samples from the non-smoking
control group (E1=N, t1; E2=N, t2; E3=N, t3). A wider
separation is to be seen in the smoking control group (E4= S, t1;
E5=S, t2; E6= S, t3), however almost exclusively alongside the
second principal component axis (IPCA2), reflecting a substantially
smaller difference (37.7%).
(TIF)
Figure S3 Distribution of phyla in all samples in
percentages. The fraction other (0.1% of all sequences) in the
right pie chart consists of Synergistetes, Fusobacteria, Deinococcus-
Thermus, TM7, Acidobacteria and OD1.
(TIF)
Figure S4 Composition of phyla per individual. The
fractions of the four most abundant phyla and changes over time
are depicted. Individuals within a group are aligned based on
abundance of Firmicutes. While there is an relatively stable
composition per individual in the non-smoking (N1-5) and
smoking (S1-5) control groups, obvious shifts in the subjects from
the intervention group (I1-10) can be detected between the time
points before (t1) and after (t2, t3) smoking cessation.
(TIF)
Figure S5 Heat map with color-coded significance
levels. The results of paired Student’s T-Test is depicted on the
level of phylum (analogs to Main Figure 1b) including separate
analysis for all genera constituting each phylum.
(TIF)
Figure S6 Weighted PCA. Analog to Main Figure 2.
Findings are similar to the unweighted analysis. Again a clear
separation of samples of the intervention group is obvious.
Although there is some variation in the non-smoking Control
group (N) as well, the difference is notably smaller (smoking
control group =S).
(TIF)
Figure S7 Jackknife analysis. In this statistical approach to
test for reproducibility of results, resampling is done several times
with a number of sequences (in general sample size of around 75%
of the number of sequences in the sample with the lowest count is
recommended (runs were performed with sample size 18000). To
increase statistical power we set number of permutations to 1000.
QIIME constructs a color coded bootstrapped tree (red = 75–
100% support, yellow = 50–75%, green= 25–50% and blue for
,25%; unweighted (A) and weighted (B) tree). The number
besides the nodes indicates the percentage of how many times the
node was reproduced during resampling. A perfectly high
reproducibility can be seen.
(TIF)
Figure S8 PD and PD-Endemism. There are substantially
higher values in the intervention group after smoking cessation.
PD-Endemism refers to the amount of branch length that is
uniquely represented by a certain environment while PD is
indicative of the total phylogenetic branch length, that is spanned
by all species included in the environment.
(TIF)
Figure S9 Rarefaction curves (analog to main Figure 3b;
curves express the accumulation of phylogenetic rich-
ness that would be obtained with continuous sampling
effort and hence minimize potential differences that
would be a result of the variable number of sequences
obtained per sample). In addition to the phylogeny-based PD
whole tree (phylogenetic tree is needed for calculation of this a-
diversity measure) (A), two further indices of a-diversity, chao1 (B)
and observed species (C) are depicted. The latter two indices
reveal a significantly increased a-diversity also 8 weeks after
smoking cessation. For the control groups the three sampling time
points were combined in a single curve, while for the intervention
group separated curves for t1, t2 and t3 were depicted to visualize
the increased microbial diversity (PD) in the samples 4 weeks after
smoking cessation (I2) compared to I1 and I3.
(TIF)
Table S1 Evolution of body weight and BMI in the 10
subjects undergoing smoking cessation.
(TIF)
Table S2 Overview of individual calorie intake in the 10
subjects undergoing smoking cessation.
(TIF)
Table S3 Paired T-Test (Comparison of total calories as
well as fraction of carbohydrates, proteins, fat fibers
and alcohol between t1, t2 and t3). With the exception of
calories from alcohol between t2 and t3 no significant changes are
detected.
(TIF)
Table S4 Summary of additive main effects and multi-
plicative interaction model (AMMI) results. Table A shows
the results of the analysis of variance (ANOVA) with a two-way
data matrix (df = degrees of freedom, SS = sum of squares and
MS = mean square). Table B shows the interaction sums of
squares (SS), giving an estimate of the contribution of idiosyncratic
noise to the observed pattern, which in this case is regarded as
meaningful. However, the value for the interaction pattern is
clearly positive (a negative value would occur if the estimated
interaction noise is more meaningful than the interaction total).
Table C shows the per cent of variation from each source in
AMMI (while main effects variation reflects variation from T-RFs
and Environments, replicated data interaction effects reflects
interaction pattern and interaction noise; variation due to
Interaction Effects reflect dissimilarity of the investigated microbial
communities). Table D shows how much of the predicted
interaction signal variation is captured in the first IPCAs (in the
table the first four IPCAs are depicted; here complete capture is
already achieved with 3 axes.
(TIF)
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